AMD

Latest News

 InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company
InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company

January 19th 2025

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration (iAMD) and diabetic retinal eye disease.

Outlook Therapeutics completes analysis of 12-week safety and efficacy results of NORSE EIGHT
Outlook Therapeutics completes analysis of 12-week safety and efficacy results of NORSE EIGHT

January 16th 2025

Ashvattha Therapeutics secures $50M in financing to advance clinical trials
Ashvattha Therapeutics secures $50M in financing to advance clinical trials

January 15th 2025

4DMT refocuses pipeline to prioritize 4D-150 trials in wet AMD and DME
4DMT refocuses pipeline to prioritize 4D-150 trials in wet AMD and DME

January 13th 2025

Latest CME Events & Activities

Illuminating the Power of Collaborative Care in nAMD and DME: Advancing the Shift to Treatment Innovations

February 2, 2025

Register Now!

EnVision Summit

February 14-17, 2025

Register Now!

Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments

March 9, 2025

Register Now!

Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care

View More

CRU Eye Symposium

March 28-30, 2025

Register Now!

Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)

View More

Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)

View More

Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)

View More

Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)

View More

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)

View More

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)

View More

Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)

View More

Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)

View More

Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)

View More

Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)

View More

Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)

View More

Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)

View More

19th Annual Controversies in Modern Eye Care

May 4, 2025

Register Now!

(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease

View More

(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease

View More

Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)

View More

Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)

View More

Collaborative Care Symposium

May 30-31, 2025

Register Now!

Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data

View More

Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy

View More

Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease

View More

Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)

View More

Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)

View More

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)

View More

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)

View More

More News

© 2025 MJH Life Sciences

All rights reserved.